跳至主要内容
临床试验/NCT07113301
NCT07113301进行中(未招募)不适用

Evaluation of Agreement in Histological Findings Between Core Needle and Incisional Biopsies

Istituto Ortopedico Rizzoli1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2024年11月5日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
42
试验地点
1
主要终点
compare the agreement between core needle biopsy and incisional biopsy, based on Cohen's kappa coefficient.

研究概览

简要总结

The investigators will collect data of patients with high suspicion of malignant bone tumor based on radiological imaging who underwent/will undergo both core needle biopsy and incisional biopsy for diagnostic confirmation by histological examination.

From 01/01/2015 to the approval date of this study: retrospective study; from the approval date of this study to 31/12/2027: prospective study. the investigators expect to collect data from a total of 72 patients: approximately 30 patients for the retrospective study and 42 for the prospective study. A review will be made from the medical records, radiological imaging, and histological data of partecipants.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 2 years
  • Patients with high suspicion of malignant bone tumor who underwent/will undergo both core needle biopsy and incisional biopsy
  • Male and female patients treated at Rizzoli Orthopaedic Institute from the approval date of this study to 31/12/2027
  • Patients with available clinical and imaging data

排除标准

  • Patients with bone tumor who underwent/will undergo only core needle biopsy
  • Patients with bone tumor who underwent/ will undergo only incisional biopsy

结局指标

主要结局

compare the agreement between core needle biopsy and incisional biopsy, based on Cohen's kappa coefficient.

时间窗: through study completion, an average of 3 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant DiseaseMalignant NeoplasmsHereditary Neoplastic SyndromesKidney CancerRenal CancerBladder Cancer
NCT00026884National Cancer Institute (NCI)5,950
终止
不适用
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceNeoplasmsLung NeoplasmsColon NeoplasmsBreast NeoplasmsPancreatic NeoplasmsProstate NeoplasmsKidney NeoplasmsLiver NeoplasmsRectal NeoplasmsHematologic NeoplasmsMyelodysplastic SyndromesOvarian NeoplasmsBladder NeoplasmsTesticular NeoplasmsEndometrial NeoplasmsBrain NeoplasmsBiliary Tract NeoplasmsHead and Neck NeoplasmsUterine Cervical NeoplasmsSkin NeoplasmsGastric NeoplasmsAnal NeoplasmsMultiple MyelomaMelanomaSarcoma
NCT02900248CureOne23
已完成
不适用
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid LeukemiaLeukemia
NCT00899743SWOG Cancer Research Network132
已完成
不适用
Study of Tumor Samples From Patients With Stage III Colon Cancer Who Have Undergone Surgery and ChemotherapyColorectal Cancer
NCT00918827Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan2,128
招募中
不适用
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical ResearchMalignant Solid TumorsPrimary Brain TumorSoft Tissue SarcomaKidney CancerColorectal CancerMelanomaProstate Cancer
NCT05539677N.N. Petrov National Medical Research Center of Oncology1,000